Clinicians in the dental sphere are still yearning for more robust and predictable tissue regeneration and regenerative medicine models; more so because even though related technologies have proved viable in animal specimens, most are yet to be rolled out in clinics and health centers. Factors contributing to this limitation include: tech developments without a relevant context, resultant outcomes not conforming to standards of care, plus the lack of a large dental and craniofacial (DOC) presence in the biotech and pharmaceutical spheres.
So to overcome these limitations, the National Institutes of Health (NIDCR) has recently inaugurated the DOCTRC program. The venture is most importantly configured to engage clinicians from the onset of technological advancement, with the main aim being to develop resources and strategies for regenerating DOC tissues. The expedition has already seen two subsidiary resource centers being established: the Michigan-Pittsburgh-Wyss Resource Center, and the Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration which is an association of California universities.
The latter is currently preparing for a flagship convention wherein invaluable propositions on the same subject will be tabled by specialists from the NIDCR, from various universities, and from journals involved in dental research. Overseers are hoping to emulate a recent symposium dubbed “Dental Oral Craniofacial Tissue Regeneration Consortia: A New Paradigm,” an initiative from America’s and Canada’s Associations for Dental Research.
Reference
https://www.sciencedaily.com/releases/2018/03/180323093739.htm